European Inhaler Market Trends, Size, Share, Analysis and Forecast 2019-2025

European inhaler market was valued at around $6.4 billion in 2018 and is anticipated to grow at a substantial rate of 2.3% during the forecast period. Major countries that will contribute to the inhaler market within the region includes UK, Germany, France, Italy and Spain. A significant number of companies, research, patient base has been observed in the market due to which a significant growth can be observed in the market. According to the International Monetary Fund (IMF), Europe is home to around 740 million people and the GDP of the European Union is $19.7 trillion in 2017. As per Organization for Economic Co-operation and Development (OECD), the self-reported asthma rate and COPD rate by European Union countries were 6.1% and 4.0% respectively and it has been found out that the rate of prevalence of diseases are higher in women as compared to men. This is expected to drive the regional business growth of the inhaler market.

Get Sample Copy of European Inhaler Market at: https://www.omrglobal.com/request-sample/european-inhaler-market

The major players of the European inhaler market include Boehringer Ingelheim International GmbH, AstraZeneca PLC, GlaxoSmithKline PLC, Novartis AG, Teva Pharmaceuticals Industries Ltd., Koninklijke Philips N.V., and Bespak.

The European inhaler market is segmented on the basis of device, type, application, and end-user. On the basis of device, the market is sub-segmented into metered dosed inhaler, dry powdered inhaler, and nebulizer. The dry powder inhaler is estimated to have largest market share in the European inhaler market due to providing easy inhalation solution. Whereas, the market for metered dose inhaler is estimated to be the fastest growing at a CAGR during the forecast period owing to innovations and collaborations by the companies for the development of metered dosed inhaler. Based on the type, preventive, reliever, and long acting bronchodilators inhaler are analyzed. Moreover, on the basis of application, the market has been classified into asthma and COPD diseases. In addition, based on the end-user, homecare and hospitals and clinics have been analyzed.

For More Information get A full report of European Inhaler is available at: https://www.omrglobal.com/industry-reports/european-inhaler-market

Furthermore, the market is characterized by the presence of several manufacturers that are developing and providing inhaler to cater to a wide range of customers within the region and across the globe. These players adopt various strategies to capitalize on market growth opportunities. Mergers and acquisitions, product launch, geographical expansion, partnerships, and collaborations are the majorly adopted strategies by the market players.

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/european-inhaler-market

European Inhaler Market Segmentation

European Inhaler Market by Device

• Metered Dose Inhaler
• Dry Powder Inhaler
• Nebulizer

European Inhaler Market by Type

• Preventive Inhaler
• Reliever Inhaler
• Long Acting Bronchodilators Inhaler

European Inhaler Market by Application

• Asthma
• Chronic Obstructive Pulmonary Disease (COPD)

European Inhaler Market by End-User

• Homecare
• Hospitals and Clinics

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 7803040404

About Orion Market Research

OMR provide global and regional market reports of various domains such as healthcare, energy, IT, chemicals, and automobiles. OMR provide a 360-degree view of the market with parametric analysis, key market insights, key findings, statistical forecasts, competitive landscape, extensive segmentation, key trends, strategic recommendations and detailed company profiles.

For More Information, Visit https://www.omrglobal.com/

This release was published on openPR.